News & Views
Strategic Appointment to take Cell Therapies Forward
Oct 19 2019
A UK company aiming to transform the development of cell therapies has announced the appointment of Dr. Jane Osbourn, OBE as Chair of the Board. In addition to this role at Cambridge-based Mogrify, Dr. Osbourn will become a Member of the Scientific Advisory Board supporting therapeutic program selection, industrial partner development, mentoring and investor relations.
Dr. Osbourn has over 30 years’ experience in biologics discovery and development. Most recently, she was Vice President for Research and Development and Site Leader at MedImmune (AstraZeneca), formerly Cambridge Antibody Technology (CAT), where she contributed to the development of phage display technology. She is a scientific leader in the field of antibody engineering and has made a significant contribution to the discovery and development of eight marketed drugs (including HUMIRA® and BENLYSTA®) and over 40 clinical candidates. The originator of several key publications and patents, she has presented at a number of parliamentary Select Committees. Dr. Osbourn is also Chair of the Board of Directors of the BioIndustry Association, a Director of Babraham Bioscience Technologies, a Director of Cambridge Enterprise and was awarded an OBE this year for services to drug discovery, development and biotechnology. She holds a doctorate from the John Innes Institute in Norwich, UK and a first-class degree in natural sciences from the University of Cambridge.
Dr. Osbourn said: “Mogrify’s leadership team is of high commercial and scientific caliber; it was founded by leading academics in bioinformatics, machine learning and cell reprograming and the Company has continued to strengthen its management and scientific teams with its recent move to state-of-the-art facilities on Cambridge Science Park. Mogrify's platform has the ability to address many of the current challenges of cell therapy, which is an area of significant innovation and opportunity - I am very excited to join the company at this stage in its development and look forward to its continued success.”
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan